Vicore Pharma Holding AB
556680-3804ActiveDeveloping novel ATRAG drugs for severe respiratory diseases.
Clinical-Stage Pharmaceutical Companyvicorepharma.com
Overview
- 5–9
- Employees
- 100–500M SEK
- Revenue
- 2005
- Founded
Description
Vicore is an innovative, clinical-stage pharmaceutical company focused on developing life-changing treatments for severe diseases where the AT2 receptor plays a central role. Their primary ambition is unlocking the potential of Angiotensin II Type 2 Receptor Agonists (ATRAGs), a new class of drugs w...
Tags
B2BB2C
CALLUNA PHARMA AS